The small airways and distal lung compartment in asthma and COPD: A time for reappraisal

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 65, Issue 2, 2010, Pages 141-151

  Contoli, M ^a   Bousquet, J ^b   Fabbri, L M ^c   Magnussen, H ^d   Rabe, K F ^e   Siafakas, N M ^f   Hamid, Q ^g   Kraft, M ^h  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIV MONTPELLIER   (France)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d KRANKENHAUS GROSSHANSDORF   (Germany)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^g MCGILL UNIVERSITY   (Canada)

^h DUKE UNIVERSITY   (United States)

Author keywords

Airway inflammation; Asthma; Chronic obstructive pulmonary disease (COPD); Small airways; Treatment

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID DERIVATIVE; FORMOTEROL; NITRIC OXIDE;

AIRWAY; AIRWAY OBSTRUCTION; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HUMAN; NITROGEN WASHOUT; NUCLEAR MAGNETIC RESONANCE IMAGING; OSCILLOMETRY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SINGLE BREATH NITROGEN TEST; SPIROMETRY;

ADRENAL CORTEX HORMONES; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHIOLES; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS;

EID: 73549101104     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/j.1398-9995.2009.02242.x     Document Type: Review

References (70)

1. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention: NHLBI/WHO workshop report. 2002. NIH Publication report : Bethesda : National Institutes of Health, National Heart, Lung and Blood Institute, 2002 : 1 116. Publication No. 02-3659. Last Update 2008. Available on-line at www.ginasthma.com S, Saetta M, Cosio MG. Pathophysiology of the small airways. Semin Respir Crit Care Med 2003 24 : 465 472.
2. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004 350 : 2645 2653.
3. Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978 298 : 1277 1281.
4. van Veen IH, Sterk PJ, Schot R, Gauw SA, Rabe KF, Bel EH. Alveolar nitric oxide versus measures of peripheral airway dysfunction in severe asthma. Eur Respir J 2006 27 : 951 956.
5. Stanescu D, Sanna A, Veriter C, Robert A. Identification of smokers susceptible to development of chronic airflow limitation: a 13-year follow-up. Chest 1998 114 : 416 425.
6. Kraft M, Cairns CB, Ellison MC, Pak J, Irvin C, Wenzel S. Improvements in distal lung function correlate with asthma symptoms after treatment with oral Montelukast. Chest 2006 130 : 1726 1732.
7. Sutherland ER, Martin RJ, Bowler RP, Zhang Y, Rex MD, Kraft M. Physiologic correlates of distal lung inflammation in asthma. J Allergy Clin Immunol 2004 113 : 1046 1050.
8. Kraft M, Pak J, Martin RJ, Kaminsky D, Irvin CG. Distal lung dysfunction at night in nocturnal asthma. Am J Respir Crit Care Med 2001 163 : 1551 1556.
9. Papi A, Paggiaro P, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone/formoterol vs fluticasone/salmeterol inhaled combination in moderate to severe asthma. Allergy 2007 62 : 1182 1188.
10. Kaminsky DA, Irvin CG, Lundblad L, Moriya HT, Lang S, Allen J et al. Oscillation mechanics of the human lung periphery in asthma. J Appl Physiol 2004 97 : 1849 1858.
11. Kolsum U, Borrill Z, Roy K, Starkey C, Vestbo J, Houghton C et al. Impulse oscillometry in COPD: identification of measurements related to airway obstruction, airway conductance and lung volumes. Respir Med 2009 103 : 136 143.
12. Goldman MD. Clinical application of forced oscillation. Pulm Pharmacol Ther 2001 14 : 341 350.
13. Borrill ZL, Houghton CM, Tal-Singer R, Vessey SR, Faiferman I, Langley SJ et al. The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD. Br J Clin Pharmacol 2008 65 : 244 252.
14. Bourdin A, Paganin F, Prefaut C, Kieseler D, Godard P, Chanez P. Nitrogen washout slope in poorly controlled asthma. Allergy 2006 61 : 85 89.
15. in't Veen JC, Beekman AJ, Bel EH, Sterk PJ. Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes. Am J Respir Crit Care Med 2000 161 : 1902 1906.
16. Brundler JP, Lewis CM, De Kock MA. Functional classification of chronic airflow limitation based on flow-volume and single-breath nitrogen washout criteria. Respiration 1983 44 : 1 9.
17. Gershman NH, Liu H, Wong HH, Liu JT, Fahy JV. Fractional analysis of sequential induced sputum samples during sputum induction: evidence that different lung compartments are sampled at different time points. J Allergy Clin Immunol 1999 104 : 322 328.
18. Holz O, Jörres RA, Koschyk S, Speckin P, Welker L, Magnussen H. Changes in sputum composition during sputum induction in healthy and asthmatic subjects. Clin Exp Allergy 1998 28 : 284 292.
19. Magnussen H, Holz O. Monitoring airway inflammation in asthma by induced sputum. Eur Respir J 1999 13 : 5 7.
20. Richter K, Holz O, Jorres RA, Mucke M, Magnussen H. Sequentially induced sputum in patients with asthma or chronic obstructive pulmonary disease. Eur Respir J 1999 14 : 697 701.
21. Tsoumakidou M, Tzanakis N, Siafakas NM. Induced sputum in the investigation of airway inflammation of COPD. Respir Med 2003 97 : 863 871.
22. Hauber HP, Taha R, Bergeron C, Migounov V, Hamid Q, Ron Olivenstein R. Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients. Can Respir J 2006 13 : 73 78.
23. Brindicci C, Ito K, Resta O, Pride NB, Barnes PJ, Kharitonov SA. Exhaled nitric oxide from lung periphery is increased in COPD. Eur Respir J 2005 26 : 52 59.
24. Brindicci C, Ito K, Barnes PJ, Kharitonov SA. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest 2007 131 : 1353 1362.
25. de Jong PA, Muller NL, Pare PD, Coxson HO. Computed tomographic imaging of the airways: relationship to structure and function. Eur Respir J 2005 26 : 140 152.
26. Mikos M, Grzanka P, Sladek K, Pulka G, Bochenek G, Soja J et al. High-resolution computed tomography evaluation of peripheral airways in asthma patients: comparison of focal and diffuse air trapping. Respiration 2009 77 : 381 388.
27. Ueda T, Niimi A, Matsumoto H, Takemura M, Hirai T, Yamaguchi M et al. Role of small airways in asthma: investigation using high-resolution computed tomography. J Allergy Clin Immunol 2006 118 : 1019 1025.
28. Cohen J, Douma WR, ten Hacken NHT, Vonk JM, Oudkerk M, Postma DS. Ciclesonide improves measures of small airway involvement in asthma. Eur Respir J 2008 31 : 1213 1220.
29. Omori H, Fujimoto K, Katoh T. Computed-tomography findings of emphysema: correlation with spirometric values. Curr Opin Pulm Med 2008 14 : 110 114.
30. Jain N, Covar RA, Gleason MC, Newell JD Jr., Gelfand EW, Spahn JD. Quantitative computed tomography detects peripheral airway disease in asthmatic children. Pediatr Pulmonol 2005 40 : 211 218.
31. Goldin JG, Tashkin DP, Kleerup EC, Greaser LE, Haywood UM, Sayre JW et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 1999 104 : S258 S267.
32. Zeidler MR, Kleerup EC, Goldin JG, Kim HJ, Truong DA, Simmons MD et al. Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J 2006 27 : 307 315.
33. Samee S, Altes T, Powers P, de Lange EE, Knight-Scott J, Rakes G et al. Imaging the lungs in asthmatic patients by using hyperpolarized helium-3 magnetic resonance: assessment of response to methacholine and exercise challenge. J Allergy Clin Immunol 2003 111 : 1205 1211.
34. Evans A, McCormack DG, Santyr G, Parraga G. Mapping and quantifying hyperpolarized 3He magnetic resonance imaging apparent diffusion coefficient gradients. J Appl Physiol 2008 105 : 693 699.
35. Kauczor HU, Chen XJ, van Beek EJ, Schreiber WG. Pulmonary ventilation imaged by magnetic resonance: at the doorstep of clinical application. Eur Respir J 2001 17 : 1008 1023.
36. Fain SB, Korosec FR, Holmes JH, O'Halloran R, Sorkness RL, Grist TM. Functional lung imaging using hyperpolarized gas MRI. J Magn Reson Imaging 2007 25 : 910 923.
37. de Lange EE, Altes TA, Patrie JT, Gaare JD, Knake JJ, Mugler JP III. et al. Evaluation of asthma with hyperpolarized helium-3 MRI: correlation with clinical severity and spirometry. Chest 2006 130 : 1055 1062.
38. Yablonskiy DA, Sukstanskii AL, Leawoods JC, Gierada DS, Bretthorst GL, Lefrak SS et al. Quantitative in vivo assessment of lung microstructure at the alveolar level with hyperpolarized 3He diffusion MRI. Proc Natl Acad Sci USA 2002 99 : 3111 3116.
39. Kraft M, Djukanovic R, Wilson S, Holgate ST, Martin RJ. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996 154 : 1505 1510.
40. Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992 72 : 1016 1023.
41. Mitchell HW, Cvetkovski R, Sparrow MP, Gray PR, McFawn PK. Concurrent measurement of smooth muscle shortening, lumen narrowing and flow to acetylcholine in large and small porcine bronchi. Eur Respir J 1998 12 : 1053 1061.
42. Ellis JL, Hubbard WC, Meeker S, Undem BJ. Ragweed antigen E and anti-IgE in human central versus peripheral isolated bronchi. Am J Respir Crit Care Med 1994 150 : 717 723.
43. Wagner EM, Bleecker ER, Permutt S, Liu MC. Direct assessment of small airways reactivity in human subjects. Am J Respir Crit Care Med 1998 157 : 447 452.
44. Corren J. Small airways disease in asthma. Curr Allergy Asthma Rep 2008 8 : 533 539.
45. Tulic MK, Christodoulopoulos P, Hamid Q. Small airway inflammation in asthma. Respir Res 2001 2 : 333 339.
46. Hamid Q, Song Y, Kotsimbos TC, Minshall E, Bai TR, Hegele RG et al. Inflammation of small airways in asthma. J Allergy Clin Immunol 1997 100 : 44 51.
47. Hamid QA. Peripheral inflammation is more important than central inflammation. Respir Med 1997 91 (Suppl A 11 12.
48. Kraft M, Martin RJ, Wilson S, Djukanovic R, Holgate ST. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 1999 159 : 228 234.
49. Jeffery PK. Remodeling and inflammation of bronchi in asthma and chronic obstructive pulmonary disease. Proc Am Thorac Soc 2004 1 : 176 183.
50. Ebina M, Takahashi T, Chiba T, Motomiya M. Cellular hypertrophy and hyperplasia of airway smooth muscles underlying bronchial asthma. A 3-D morphometric study. Am Rev Respir Dis 1993 148 : 720 726.
51. Kuwano K, Bosken CH, Pare PD, Bai TR, Wiggs BR, Hogg JC. Small airways dimensions in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993 148 : 1220 1225.
52. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004 170 : 836 844.
53. Haussermann S, Acerbi D, Brand P, Herpich C, Poli G, Sommerer K et al. Lung deposition of formoterol HFA (Atimos/Forair) in healthy volunteers, asthmatic and COPD patients. J Aerosol Med 2007 20 : 331 341.
54. Leach CL, Davidson PJ, Hasselquist BE, Boudreau RJ. Lung deposition of hydrofluoroalkane-134a beclomethasone is greater than that of chlorofluorocarbon fluticasone and chlorofluorocarbon beclomethasone: a cross-over study in healthy volunteers. Chest 2002 122 : 510 516.
55. Hampel F, Lisberg E, Guerin JC. Effectiveness of low doses (50 and 100 microg b.i.d) of beclomethasone dipropionate delivered as a CFC-free extrafine aerosol in adults with mild to moderate asthma. Study Group. J Asthma 2000 37 : 389 398.
56. Holz O, Zuhlke I, Einhaus M, Welker L, Kanniess F, Branscheid D et al. Direct measurement of BDP and 17-BMP in bronchial and peripheral lung tissue after inhalation of HFA- vs CFC-driven aerosols. Pulm Pharmacol Ther 2004 17 : 233 238.
57. Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999 104 : 1215 1222.
58. Van Schayck CP, Donnell D. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults. Int J Clin Pract 2004 58 : 678 688. (Pubitemid 39144583)
59. Papi A, Paggiaro PL, Nicolini G, Vignola AM, Fabbri LM. Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. Eur Respir J 2007 29 : 682 689.
60. Marshall BG, Wangoo A, Harrison LI, Young DB, Shaw RJ. Tumour necrosis factor-alpha production in human alveolar macrophages: Modulation by inhaled corticosteroid. Eur Respir J 2000 15 : 764 770.
61. Ohbayashi H, Adachi M. Hydrofluoroalkane-Beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study. Allergology International 2008 57 : 1 9.
62. Huchon G, Magnussen H, Chuchalin A, Dymek L, Gonod FB, Bousquet J. Lung function and asthma control with beclomethasone and formoterol in a single inhaler. Respir Med 2009 103 : 41 49.
63. Ohbayashi H. One-year evaluation of the preventative effect of hydrofluoroalkane-beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways. Respiration 2007 74 : 146 153.
64. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998 157 : 822 826.
65. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet 2004 364 : 709 721.
66. Sturton G, Persson C, Barnes PJ. Small airways: an important but neglected target in the treatment of obstructive airway diseases. Trends Pharmacol Sci 2008 29 : 340 345.
67. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009 360 : 2445 2454.
68. Persson CG. Small airway relaxation - a forgotten medical need. Pulm Pharmacol Ther 2008 21 : 1 3.
69. 2 adrenoceptor agonist, on small airways in human and rat precision-cut lung slices. J Pharmacol Exp Ther 2008 324 : 270 275.
70. John M, Bosse S, Oltmanns U, Schumacher A, Witt C. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease. Respir Med 2005 99 : 1418 1424.